Relief Therapeutics Holding (XSWX:RLF) EV-to-FCF

Relief Therapeutics Holding Annual Data
	Trend	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22
EV-to-FCF							-24.66	-4.05	-45.75	-4.33	-4.71

Relief Therapeutics Holding Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
EV-to-FCF																-	-4.33	-	-4.71	-

For the Biotechnology subindustry, Relief Therapeutics Holding's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

For the Biotechnology industry and Healthcare sector, Relief Therapeutics Holding's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Relief Therapeutics Holding's EV-to-FCF falls into.

Relief Therapeutics Holding EV-to-FCF Calculation

Relief Therapeutics Holding's EV-to-FCF for today is calculated as:

Relief Therapeutics Holding's current Enterprise Value is CHF6.45 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Relief Therapeutics Holding's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2023 was CHF-20.62 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Relief Therapeutics Holding  (XSWX:RLF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Relief Therapeutics Holding's PE Ratio for today is calculated as:

Relief Therapeutics Holding's share price for today is CHF1.31.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Relief Therapeutics Holding's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was CHF-7.347.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Relief Therapeutics Holding EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Relief Therapeutics Holding's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Relief Therapeutics Holding (XSWX:RLF) Business Description